NDC 68071-1890-06 - VENTOLIN HFA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-1890
- Requested NDC
- 68071-1890-06
- Package NDCs from labels
- 68071-1890-6, 68071-1890-06
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-07-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VENTOLIN HFA - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-07-16 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-1890-6 | VENTOLINHFA | 60 in 1 BOX | AEROSOL, METERED | 60 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-1890 | VENTOLIN HFA (ALBUTEROL SULFATE) AEROSOL, METERED [NUCARE PHARMACEUTICALS,INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20240717_7043bc12-8a58-8ff8-e053-2a91aa0ab627.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VENTOLIN HFA | ALBUTEROL SULFATE | GlaxoSmithKline LLC | d92c5d6b-ff10-4087-36a2-1cfc464cb967 | 2024-04-26 | Warnings, Adverse reactions | NDA020983 0173-0682 859088 801092 801095 2123076 08d3613c-b059-4e06-b42c-591a129f1649 d92c5d6b-ff10-4087-36a2-1cfc464cb967 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 767a1504-1e04-1e06-e053-2a91aa0aa4b6 | 2024-02-22 | Warnings, Adverse reactions | NDA020983 801092 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC. | 7f261a9b-65d9-408a-8609-c1b3809b8b4b | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 4e48ccbe-3ec0-4bf2-be28-83eb9baa63d6 | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 922bf33b-4d55-4c35-9f68-72efbb17c14f | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | A-S Medication Solutions | 7ad17b39-d2de-4108-abbf-cedd650c8edd | 2024-02-18 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Cipla USA Inc. | 89d59bd9-c826-413c-8ed9-a1521a0c7cc5 | 2024-01-11 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Proficient Rx LP | a1d9d346-91a5-4f5a-82ed-4ebeaf350a06 | 2024-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Asclemed USA, Inc. | a69489f7-4ffb-4cd1-b2d2-002f48e84f51 | 2023-12-19 | Boxed warning, Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Aurobindo Pharma Limited | 370516c4-718f-4a71-bdc8-8822060ccefe | 2023-10-31 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 07b1ee8b-d920-49dd-9fad-cb0fe8a35e0d | 2023-10-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Proficient Rx LP | d617e361-5c03-45ac-9bbe-0fa418edb19f | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | Proficient Rx LP | 6dc143e7-6bab-42c8-b3e9-9d604d202e73 | 2023-10-01 | Warnings, Adverse reactions | NDA020983 859088 801092 801095 2123076 021SEF3731 |
| Albuterol | ALBUTEROL | Zydus Pharmaceuticals USA Inc. | c3fa0068-fd12-45de-818e-e929fb45ba05 | 2023-08-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | A-S Medication Solutions | 8f52f15f-3fb7-4b00-a19f-8721c5ac55db | 2023-07-24 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 81cdae6f-99d7-468b-9ab8-fecb1d42298d | 2023-06-19 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Medical Purchasing Solutions, LLC | 6a4b4b95-d1d3-9051-e053-2a91aa0a52e8 | 2023-05-30 | Warnings, Adverse reactions | 021SEF3731 |
| albuterol sulfate HFA | ALBUTEROL SULFATE | A-S Medication Solutions | 4378c5b0-529f-44b4-bdf1-e9f2631df8cd | 2023-02-06 | Warnings, Adverse reactions | NDA020983 2123076 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Hikma Pharmaceuticals USA Inc. | 6c64ab5d-f8a2-440a-a929-cb8188d0e8b4 | 2023-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 4100bce5-096c-42e4-9e4e-d11a0ab597d5 | 2023-01-01 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.